Ovarian Hormone-Dependent Effects of Dietary Lipids on APP/PS1 Mouse Brain
Open Access
- 19 December 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 11, 346
- https://doi.org/10.3389/fnagi.2019.00346
Abstract
The formation of senile plaques through amyloid-β peptide (Aβ) aggregation is a hallmark of Alzheimer’s disease (AD). Irrespective of its actual role in the synaptic alterations and cognitive impairment associated with AD, different therapeutic approaches have been proposed to reduce plaque formation. In rodents, daily intake of omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFAs) is required for neural development, and there is experimental and epidemiological evidence that their inclusion in the diet has positive effects on several neurodegenerative diseases. Similarly, estradiol appears to reduce senile plaque formation in primary mouse cell cultures, human cortical neurons and mouse AD models, and it prevents Aβ toxicity in neural cell lines. We previously showed that differences in dietary n-6/n-3 LC-PUFAs ratios modify the lipid composition in the cerebral cortex of female mice and the levels of amyloid precursor protein (APP) in the brain. These effects depended in part on the presence of circulating estradiol. Here we explored whether this potentially synergistic action between diet and ovarian hormones may influence the progression of amyloidosis in an AD mouse model. Our results show that a diet with high n-3 LC-PUFA content, especially DHA (22:6n-3), reduces the hippocampal accumulation of Aβ1–40, but not amyloid Aβ1–42 in female APPswe/PS1 E9A mice, an effect that was counteracted by the loss of the ovaries and that depended on circulating estradiol. In addition, this interaction between dietary lipids and ovarian function also affects the composition of the brain lipidome as well as the expression of certain neuronal signaling and synaptic proteins. These findings provide new insights into how ovarian hormones and dietary composition affect the brain lipidome and amyloid burden. Furthermore, they strongly suggest that when designing dietary or pharmacological strategies to combat human neurodegenerative diseases, hormonal and metabolic status should be specifically taken into consideration as it may affect the therapeutic response.Keywords
Funding Information
- Agencia Estatal de Investigación (BFU2017-82754-R, SAF2007-66148-C02-01, SAF2015-70368-R)
- Comunidad de Madrid
- Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable
This publication has 91 references indexed in Scilit:
- Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic miceNeurobiology of Disease, 2012
- The Salutary Effects of DHA Dietary Supplementation on Cognition, Neuroplasticity, and Membrane Homeostasis after Brain TraumaJournal of Neurotrauma, 2011
- Specialized pro-resolving lipid mediators in the inflammatory response: An updateBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- DHA diet reduces AD pathology in young APPswe/PS1ΔE9 transgenic mice: Possible gender effectsJournal of Neuroscience Research, 2009
- Docosahexaenoic acid promotes hippocampal neuronal development and synaptic functionJournal of Neurochemistry, 2009
- Protective actions of sex steroid hormones in Alzheimer’s diseaseFrontiers in Neuroendocrinology, 2009
- Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's diseaseNeuroscience Research, 2008
- PSD-95 is required for activity-driven synapse stabilizationProceedings of the National Academy of Sciences of the United States of America, 2007
- ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD StudyArchives of Neurology, 2006
- Mediterranean diet and risk for Alzheimer's diseaseAnnals of Neurology, 2006